In Combo Studies for the Optimization of 5-Aminoanthranilic Acid Derivatives as Potential Multitarget Drugs for the Management of Metabolic Syndrome

• Hoofdauteurs: Edwin Chávez-Gutiérrez (Auteur), Matilda Martínez-Arellanes (Auteur), Montserrat Murillo-López (Auteur), María Fernanda Medina-Guzmán (Auteur), Laila Mobarak-Richaud (Auteur), Karen Pelcastre-Guzmán (Auteur), Osvaldo Javier Quintana-Romero (Auteur), Armando Ariza-Castolo (Auteur), María del Rosario Ayala-Moreno (Auteur), Juan Rodrigo Salazar (Auteur), Christian Guerra-Araiza (Auteur), Lorena Rodríguez-Páez (Auteur), Rodolfo Pinto-Almazán (Auteur), Marco A. Loza-Mejía (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2022-11-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Metabolic syndrome is a set of risk factors that consist of abdominal obesity, arterial hypertension, alterations in the lipid profile, and hyperglycemia. The current therapeutic strategy includes polypharmacy, using three or more drugs to control each syndrome component. However, this approach has...